Centenial Surgical Suture Ltd. (BOM:531380)

Market Cap	308.65M -48.8%
Revenue (ttm)	538.40M +0.6%
Net Income	-22.05M
EPS	-6.04
Shares Out	3.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Open	84.60
Previous Close	n/a
Day's Range	84.60 - 84.60
52-Week Range	73.04 - 189.00
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Centenial Surgical Suture

Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It provides absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centilene, centisilk, centlon, and centsteel; and superior atraumatic needle products. The company also provides cardiovascular sutures, which include centibond, centiiwax, ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1995
• Employees: 280
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531380

Financial Performance

In fiscal year 2026, Centenial Surgical Suture's revenue was 538.40 million, an increase of 0.61% compared to the previous year's 535.16 million. Losses were -22.05 million, 50.6% more than in 2025.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 22, 2026

Data Sources Report a data error